TrialRespiratory research2025

A composite endpoint for systemic sclerosis-associated interstitial lung disease: association with mortality in two clinical trial cohorts.

Elizabeth R Volkmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.